Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Naoe

Showing results (131-140 of 321) with videos related to

Pageof 33
Sort By:
Biochemical and Biophysical Research Communications|December 13, 2005
Identification of amino acid residues essential for heparin binding by the A1 domain of human von Willebrand factorTatsuya Adachi, Tadashi Matsushita, Zhengyu Dong, et al.
International Journal of Hematology|September 8, 2012
Phase 1 trial of gemtuzumab ozogamicin in combination with enocitabine and daunorubicin for elderly patients with relapsed or refractory acute myeloid leukemia: Japan Adult Leukemia Study Group (JALSG)-GML208 studyYoshikazu Ito, Atsushi Wakita, Satoru Takada, et al.
Cancer Genetics and Cytogenetics|August 1, 2006
Establishment of a myeloid leukemia cell line, TRL-01, with MLL-ENL fusion geneManabu Ninomiya, Akihiro Abe, Toshiya Yokozawa, et al.
Oncotarget|August 6, 2016
The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinibTakanobu Morishita, Fumihiko Hayakawa, Keiki Sugimoto, et al.
The Journal of Biological Chemistry|December 26, 2015
B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic LeukemiaNaoto Imoto, Fumihiko Hayakawa, Shingo Kurahashi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell dosesSeitaro Terakura, Eiichi Azuma, Makoto Murata, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 21, 2005
GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in JapaneseAsahi Hishida, Seitaro Terakura, Nobuhiko Emi, et al.
Pathology International|September 7, 2007
Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemiaTakashi Iwasaki, Chiho Sugisaki, Kohzo Nagata, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2004
Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantationKoji Yamamoto, Takahisa Kondo, Satoshi Suzuki, et al.
American Journal of Hematology|April 2, 2009
Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantationYoshihiro Inamoto, Shingo Kurahashi, Nobuhiko Imahashi, et al.
Pageof 33

Showing results (131-140 of 321) with videos related to

Sort By:
Pageof 33
Biochemical and Biophysical Research Communications|December 13, 2005
Identification of amino acid residues essential for heparin binding by the A1 domain of human von Willebrand factorTatsuya Adachi, Tadashi Matsushita, Zhengyu Dong, et al.
International Journal of Hematology|September 8, 2012
Phase 1 trial of gemtuzumab ozogamicin in combination with enocitabine and daunorubicin for elderly patients with relapsed or refractory acute myeloid leukemia: Japan Adult Leukemia Study Group (JALSG)-GML208 studyYoshikazu Ito, Atsushi Wakita, Satoru Takada, et al.
Cancer Genetics and Cytogenetics|August 1, 2006
Establishment of a myeloid leukemia cell line, TRL-01, with MLL-ENL fusion geneManabu Ninomiya, Akihiro Abe, Toshiya Yokozawa, et al.
Oncotarget|August 6, 2016
The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinibTakanobu Morishita, Fumihiko Hayakawa, Keiki Sugimoto, et al.
The Journal of Biological Chemistry|December 26, 2015
B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic LeukemiaNaoto Imoto, Fumihiko Hayakawa, Shingo Kurahashi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell dosesSeitaro Terakura, Eiichi Azuma, Makoto Murata, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|October 21, 2005
GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in JapaneseAsahi Hishida, Seitaro Terakura, Nobuhiko Emi, et al.
Pathology International|September 7, 2007
Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemiaTakashi Iwasaki, Chiho Sugisaki, Kohzo Nagata, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2004
Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantationKoji Yamamoto, Takahisa Kondo, Satoshi Suzuki, et al.
American Journal of Hematology|April 2, 2009
Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantationYoshihiro Inamoto, Shingo Kurahashi, Nobuhiko Imahashi, et al.
Pageof 33